Melbourne, Jan 8, 2008 (ABN Newswire) - Australian Biotech Solagran Limited (ASX: SLA) today announced it had been awarded the world's first patents protecting the use of plant polyprenols in the treatment of conditions involving physical, psychological and neurological degeneration.
